Treatment of Chronic Urticaria

Riccardo Asero, Alberto Tedeschi, Massimo Cugno

Research output: Contribution to journalArticle

Abstract

Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs. Ciclosporin is effective in most antihistamine-resistant patients who require long-term corticosteroid treatments to control their disease. Omalizumab is effective in most subsets of chronic urticaria sufferers who do not respond to other treatments but its high cost represents a limitation to its widespread use.

Original languageEnglish
Pages (from-to)105-116
Number of pages12
JournalImmunology and Allergy Clinics of North America
Volume34
Issue number1
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Urticaria
Histamine Antagonists
Adrenal Cortex Hormones
Non-Sedating Histamine H1 Antagonists
Immunosuppressive Agents
Cyclosporine
Therapeutics
Costs and Cost Analysis
Pharmaceutical Preparations

Keywords

  • Antihistamines
  • Chronic urticaria
  • Ciclosporin
  • Corticosteroids
  • Omalizumab
  • Therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Treatment of Chronic Urticaria. / Asero, Riccardo; Tedeschi, Alberto; Cugno, Massimo.

In: Immunology and Allergy Clinics of North America, Vol. 34, No. 1, 02.2014, p. 105-116.

Research output: Contribution to journalArticle

Asero, Riccardo ; Tedeschi, Alberto ; Cugno, Massimo. / Treatment of Chronic Urticaria. In: Immunology and Allergy Clinics of North America. 2014 ; Vol. 34, No. 1. pp. 105-116.
@article{ccf9677c10ac4197b8536ed439679923,
title = "Treatment of Chronic Urticaria",
abstract = "Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs. Ciclosporin is effective in most antihistamine-resistant patients who require long-term corticosteroid treatments to control their disease. Omalizumab is effective in most subsets of chronic urticaria sufferers who do not respond to other treatments but its high cost represents a limitation to its widespread use.",
keywords = "Antihistamines, Chronic urticaria, Ciclosporin, Corticosteroids, Omalizumab, Therapy",
author = "Riccardo Asero and Alberto Tedeschi and Massimo Cugno",
year = "2014",
month = "2",
doi = "10.1016/j.iac.2013.09.013",
language = "English",
volume = "34",
pages = "105--116",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Treatment of Chronic Urticaria

AU - Asero, Riccardo

AU - Tedeschi, Alberto

AU - Cugno, Massimo

PY - 2014/2

Y1 - 2014/2

N2 - Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs. Ciclosporin is effective in most antihistamine-resistant patients who require long-term corticosteroid treatments to control their disease. Omalizumab is effective in most subsets of chronic urticaria sufferers who do not respond to other treatments but its high cost represents a limitation to its widespread use.

AB - Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs. Ciclosporin is effective in most antihistamine-resistant patients who require long-term corticosteroid treatments to control their disease. Omalizumab is effective in most subsets of chronic urticaria sufferers who do not respond to other treatments but its high cost represents a limitation to its widespread use.

KW - Antihistamines

KW - Chronic urticaria

KW - Ciclosporin

KW - Corticosteroids

KW - Omalizumab

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84887992112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887992112&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2013.09.013

DO - 10.1016/j.iac.2013.09.013

M3 - Article

C2 - 24262692

AN - SCOPUS:84887992112

VL - 34

SP - 105

EP - 116

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 1

ER -